Company Analysis
Sign in

Jasper Therapeutics, Inc. (JSPR)

Nasdaq: JSPR · Biological Products, (No Diagnostic Substances) · Redwood City, CA · filing with the SEC since 2019
Full chart Alerts Compare
Grade4.1
◀ Past 2.9● Present 2.5▶ Future 6.2
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedMar 30, 2026Feb 28, 2025Mar 5, 2024Mar 8, 2023Mar 18, 2022Mar 30, 2021Mar 26, 2020
For lenders
Net interest income··-246,000-115,000-80,000-111,000·
Cost of revenue41,635,00034,268,000·····
Research and development63,104,00055,821,00051,785,00034,627,00025,421,00015,883,000·
General and administrative20,779,00020,418,00017,076,00016,569,00011,412,0004,800,000r·
Total operating expenses83,883,00076,239,00068,861,00051,196,00036,833,00020,683,000·
Total costs and expenses···1,200,0001,200,000··
Operating income-83,883,000-76,239,000-68,861,000-51,196,000-36,833,000-20,683,000r·
Interest and investment income1,741,0005,058,0005,199,000701,000·238,501·
Other income (expense), net-2,187,000-88,000-246,000586,000-80,000··
Total non-operating income (expense)8,082,0004,970,0004,396,000····
Income before income taxes·····-6,442,250r·
Income tax expense·2,0002,000··38,451·
Net income including non-controlling interests···37,700,00030,600,000r-31,669,000r·
Net income-75,801,000-71,269,000-64,465,000-37,685,000-30,637,000-31,669,000r·
Net income to common shareholders·-71,269,000-64,465,000·-30,637,000-31,669,000·
Earnings per share, basic-3.95-4.89-6.18-10.33r-26.90b··
Earnings per share, diluted-3.95-4.89-6.18-10.33r-26.90b··
Earnings per share, basic and diluted····-26.90b-51.70b·
Weighted average shares, basic19,168,11014,584,87010,439,0343,648,140r1,139,375b··
Weighted average shares, diluted19,168,11014,584,87010,439,0343,648,140r1,139,375b··
Weighted average shares, basic and diluted····1,139,375b612,590b·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:OperatingCostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton JSPR · research, not advice